Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

Completed

• Conditions: Intrahepatic Cholangiocarcinoma

• Registration Number: NCT01862276
• Lead Sponsor: Kansai Hepatobiliary Oncology Group

Brief Summary

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

Detailed Description

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Study Timeline

• Study Start: 2013-03
• Study First Submitted: 2013-05-14
• Study First Submitted QC: 2013-05-23
• Study First Posted: 2013-05-24
• Primary Completion: 2014-03
• Study Completion: 2014-03
• Status Verified: 2014-06
• Last Update Submitted: 2014-06-29
• Last Update Posted: 2014-07-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
3-year recurrence-free survival rate	11 years (2000-2010)
Ratio of local recurrence at the hepatico-duodenal ligament	11 years

Trial Locations

Locations (1)

Osaka University, Graduate School of Medicine; 🇯🇵 Osaka, Japan